N. Katakami

发表

Efficacy and safety of 10-mg azilsartan compared with 8-mg candesartan cilexetil in Japanese patients with hypertension: a randomized crossover non-inferiority trial

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Hypertension Research.

Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes

H. Kaneto, M. Matsuhisa, M. Hori, 2004, Diabetologia.

Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes

I. Shimomura, T. Matsuoka, D. Kawamori, 2018, Journal of atherosclerosis and thrombosis.

STAT3/Pim-1 signaling pathway plays a crucial role in endothelial differentiation of cardiac resident Sca-1+ cells both in vitro and in vivo.

I. Komuro, H. Kaneto, Y. Fujio, 2011, Journal of molecular and cellular cardiology.

Prediction of the presence of insulin resistance using general health checkup data in Japanese employees with metabolic risk factors.

I. Shimomura, H. Kaneto, Iichiro Shimomura, 2014, Journal of atherosclerosis and thrombosis.

Statistical reassessment of the association between waist circumference and clustering metabolic abnormalities in Japanese population.

I. Shimomura, H. Kaneto, M. Takahara, 2012, Journal of atherosclerosis and thrombosis.

Distribution of the Matsuda Index in Japanese healthy subjects

I. Shimomura, H. Kaneto, M. Takahara, 2013, Journal of Diabetes Investigation.

Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation

I. Shimomura, Y. Doki, S. Fukuda, 2021, JCI insight.

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment

I. Shimomura, S. Fukuda, H. Nishizawa, 2020, Journal of diabetes investigation.

Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells.

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2009, Current medicinal chemistry.

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

I. Shimomura, H. Kaneto, T. Matsuoka, 2021, Diabetes Therapy.

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study

I. Shimomura, H. Kaneto, H. Yokoyama, 2020, Cardiovascular Diabetology.

Efficacy of sitagliptin on blood glucose fluctuation in Japanese type 2 diabetic patients with basal-supported oral therapy.

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Endocrine journal.

Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Atherosclerosis.

Tissue characterization identifies subjects with high risk of cardiovascular diseases.

M. Matsuhisa, M. Hori, Y. Yamasaki, 2004, Diabetes research and clinical practice.

Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis

E. Fukusaki, T. Bamba, I. Shimomura, 2021, Journal of Diabetes Investigation.

Risk factor analysis for type 2 diabetic patients about hypoglycemia using continuous glucose monitoring: Results from a prospective observational study.

I. Shimomura, H. Watada, Yoshiya Tanaka, 2022, Diabetes Technology & Therapeutics.

Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study

I. Shimomura, H. Watada, Yoshiya Tanaka, 2021, Diabetes, obesity & metabolism.

Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus.

I. Shimomura, H. Kaneto, M. Matsuhisa, 2013, Endocrine journal.

Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin.

I. Shimomura, T. Matsuoka, T. Shiraiwa, 2015, Endocrine journal.

Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.

I. Shimomura, T. Matsuoka, D. Kawamori, 2018, Journal of diabetes and its complications.

Clustering of several cardiovascular risk factors affects tissue characteristics of the carotid artery.

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2008, Atherosclerosis.

Efficacy of adding once- and thrice-daily voglibose in Japanese type 2 diabetic patients treated with alogliptin.

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Endocrine journal.

Screening for a Decreased Masticatory Function by a Color-changeable Chewing Gum Test in Patients with Metabolic Disease

I. Shimomura, T. Shiraiwa, M. Takahara, 2022, Internal medicine.

Association Between the Connexin37 Polymorphism and Peripheral Arterial Disease in Subjects With Type 2 Diabetes

H. Kaneto, M. Matsuhisa, M. Hori, 2009, Diabetes Care.

Evaluation of hypertriglyceridemia using non-fasting health checkup data in a Japanese population.

I. Shimomura, H. Kaneto, M. Takahara, 2013, Journal of atherosclerosis and thrombosis.

Associations Between Continuous Glucose Monitoring-derived Metrics and Arterial Stiffness in Patients with Type 2 Diabetes

I. Shimomura, H. Watada, Y. Kojima, 2020 .

The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation

I. Shimomura, H. Watada, M. Gosho, 2017, International journal of endocrinology.

α-Glucosidase inhibitor reduces the progression of carotid intima-media thickness

M. Matsuhisa, M. Hori, Y. Yamasaki, 2005 .

Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes

I. Shimomura, H. Watada, M. Gosho, 2020, BMJ Open Diabetes Research & Care.

Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus.

I. Shimomura, H. Watada, M. Gosho, 2022, Diabetes research and clinical practice.

Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS-

E. Fukusaki, T. Bamba, I. Shimomura, 2020, Journal of atherosclerosis and thrombosis.

Association of myeloperoxidase G-463A gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic subjects.

I. Shimomura, H. Kaneto, Y. Yamasaki, 2013, Endocrine journal.

Circulating adiponectin levels and their associated factors in young lean healthy Japanese women.

T. Funahashi, I. Shimomura, H. Kaneto, 2013, Journal of atherosclerosis and thrombosis.

Glycemic control of people with diabetes over months after the 2018 North Osaka Earthquake

I. Shimomura, T. Matsuoka, M. Takahara, 2020, Diabetology International.

Contribution of visceral fat accumulation and adiponectin to the clustering of metabolic abnormalities in a Japanese population.

I. Shimomura, H. Kaneto, M. Takahara, 2014, Journal of atherosclerosis and thrombosis.

An inverse U-shaped association of late and peak insulin levels during an oral glucose load with glucose intolerance in a Japanese population: a cross-sectional study.

I. Shimomura, T. Matsuoka, M. Takahara, 2015, Endocrine journal.

Evaluation of the effect of tofogliflozin on the tissue characteristics of the carotid wall—a sub-analysis of the UTOPIA trial

I. Shimomura, H. Watada, N. Maeda, 2022, Cardiovascular Diabetology.

Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes--an 8-year prospective study.

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Atherosclerosis.

Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients.

I. Shimomura, H. Kaneto, M. Matsuhisa, 2011, Diabetes research and clinical practice.

Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes.

T. Funahashi, I. Shimomura, H. Kaneto, 2012, Atherosclerosis.

YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes research and clinical practice.

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes

I. Shimomura, T. Matsuoka, T. Hashimoto, 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.

Title Investigation of the effect of canagliflozin on the disposition index , a marker of pancreatic beta cell function , in patients with type 2 diabetes

I. Shimomura, T. Hashimoto, N. Katakami, 2022 .

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.

H. Kaneto, T. Matsuoka, Y. Nakatani, 2005, Diabetes care.

Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2013, Atherosclerosis.

Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2009, Atherosclerosis.

Serum endogenous secretory RAGE levels are inversely associated with carotid IMT in type 2 diabetic patients.

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2007, Atherosclerosis.

Endogenous secretory receptor for advanced glycation end product levels are inversely associated with HbA1c in type 2 diabetic patients.

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2006, Diabetes care.

Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes

I. Shimomura, T. Matsuoka, M. Matsuhisa, 2017, Journal of atherosclerosis and thrombosis.

Predictive impact of adiponectin for detecting dysglycemia in non-fasting Japanese employees with metabolic risk factors.

I. Shimomura, H. Kaneto, M. Takahara, 2013, Endocrine journal.

Marked recovery from glucotoxicity of β-cell function after medical nutrition therapy without pharmacotherapy in type 2 diabetic outpatients with extreme hyperglycemia: a pilot retrospective study.

I. Shimomura, T. Matsuoka, T. Shiraiwa, 2017, Endocrine journal.

Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia

I. Shimomura, H. Kaneto, T. Matsuoka, 2013, Heart and Vessels.

Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE)

I. Shimomura, T. Matsuoka, Y. Irie, 2018, Cardiovascular Diabetology.

Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial

I. Shimomura, T. Matsuoka, Y. Irie, 2018, Diabetes Therapy.

Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes research and clinical practice.

Relationship Between Carotid Intima-Media Thickness and the Presence and Extent of Coronary Stenosis in Type 2 Diabetic Patients With Carotid Atherosclerosis but Without History of Coronary Artery Disease

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes Care.

Predictive factors of posttransplant glucose intolerance in Japanese patients with type 1 diabetes after pancreas transplantation.

I. Shimomura, T. Matsuoka, M. Matsuhisa, 2019, Endocrine journal.

Regular insulin, rather than rapid‐acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Journal of diabetes investigation.

Impaired suppression of endogenous glucose production in lean Japanese patients with type 2 diabetes mellitus.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes research and clinical practice.

Efficacy of adding once-daily insulin glulisine in Japanese type 2 diabetes patients treated with insulin glargine and sitagliptin.

I. Shimomura, T. Matsuoka, T. Shiraiwa, 2014, Diabetes technology & therapeutics.

Clinical backgrounds associated with discrepancy between subjective and objective assessments of medication adherence in Japanese type 2 diabetic patients

I. Shimomura, T. Matsuoka, T. Shiraiwa, 2016, Diabetology International.

Association of serum copper levels and glycemic control in patients with type 2 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2013, Endocrine journal.

Lipid-lowering with atorvastatin improves tissue characteristics of carotid plaque.

H. Kaneto, M. Matsuhisa, M. Hori, 2005, Atherosclerosis.

Response to Comment on Mita et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 2016;39:455–464

I. Shimomura, H. Watada, N. Katakami, 2016, Diabetes Care.

Different daily glycemic profiles after switching from once-daily alogliptin plus twice-daily metformin to their once-daily fixed-dose combination in Japanese type 2 diabetic patients.

I. Shimomura, T. Matsuoka, T. Shiraiwa, 2019, Endocrine journal.

Patient Perspectives on Combination Therapy of a Once-weekly Oral Medication Plus Daily Medication for Lifestyle-related Chronic Diseases

I. Shimomura, T. Matsuoka, T. Shiraiwa, 2017, Internal medicine.

Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patients

I. Shimomura, T. Matsuoka, T. Yasuda, 2018, Journal of diabetes investigation.

Serum vitamin D levels are decreased in patients without remission of Graves’ disease

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Endocrine.

Characteristic changes in plasma glutamate levels and free amino acid profiles in Japanese patients with type 1 diabetes mellitus

I. Shimomura, Y. Ishizaka, D. Kawamori, 2022, Journal of diabetes investigation.

NAD (P) H oxidase p22 phox C242T polymorphism affects LDL particle size and insulin resistance in Japanese subjects.

M. Hori, Y. Yamasaki, T. Yasuda, 2002, Journal of atherosclerosis and thrombosis.

Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy.

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2008, Diabetes research and clinical practice.

Significant elevation of serum dipeptidyl peptidase-4 activity in young-adult type 1 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2016, Diabetes research and clinical practice.

Trends in maternal characteristics and perinatal outcomes among Japanese pregnant women with type 1 and type 2 diabetes from 1982 to 2020

I. Shimomura, M. Takahara, N. Katakami, 2022, Journal of diabetes investigation.

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus

I. Shimomura, M. Matsuhisa, A. Kuroda, 2022, Journal of diabetes investigation.

The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control

I. Shimomura, H. Watada, M. Gosho, 2022, The Journal of clinical endocrinology and metabolism.

Association Between Time in Range and HbA1c in Japanese Patients With Type 2 Diabetes Mellitus

I. Shimomura, H. Watada, Yoshiya Tanaka, 2021 .

Association of obesity, diabetes, and physical frailty with dental and tongue-lip motor dysfunctions in patients with metabolic disease.

I. Shimomura, T. Matsuoka, T. Shiraiwa, 2021, Obesity research & clinical practice.

Can soluble receptor for advanced glycation end-product (sRAGE) levels in blood be used as a predictor of cardiovascular diseases?

N. Katakami, 2017, Atherosclerosis.

Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis.

H. Kaneto, M. Matsuhisa, M. Hori, 2009, Biochemical and biophysical research communications.

Change in fatty acid composition of plasma triglyceride caused by a 2 week comprehensive risk management for diabetes: A prospective observational study of type 2 diabetes patients with supercritical fluid chromatography/mass spectrometry‐based semi‐target lipidomic analysis

I. Shimomura, H. Nishizawa, Yoshihiro Izumi, 2022, Journal of diabetes investigation.

Preference in time of insulin injection in type 2 diabetic patients treated with once‐daily long‐acting insulin analog

I. Shimomura, T. Matsuoka, T. Shiraiwa, 2016, Diabetes, obesity & metabolism.

Salivary metabolic signatures of carotid atherosclerosis in patients with type 2 diabetes hospitalized for treatment

E. Fukusaki, I. Shimomura, H. Nishizawa, 2022, Frontiers in Molecular Biosciences.

Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.

H. Kaneto, T. Matsuoka, Y. Nakatani, 2008, Endocrine journal.

PDX-1 functions as a master factor in the pancreas.

H. Kaneto, T. Matsuoka, T. Miyatsuka, 2008, Frontiers in bioscience : a journal and virtual library.

PDX-1 and MafA Play a Crucial Role in Pancreatic β-Cell Differentiation and Maintenance of Mature β-Cell Function

Yoshimitsu Yamasaki, H. Kaneto, T. Matsuoka, 2008 .

PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function.

Yoshimitsu Yamasaki, H. Kaneto, T. Matsuoka, 2008, Endocrine journal.

Involvement of oxidative stress in the pathogenesis of diabetes.

H. Kaneto, T. Matsuoka, T. Miyatsuka, 2006, Antioxidants & redox signaling.

Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes

T. Matsuoka, M. Matsuhisa, T. Yasuda, 2019, PloS one.

Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus

N. Katakami, 2018, Journal of atherosclerosis and thrombosis.

Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet α-Cells Into β-Cells In Vivo

I. Shimomura, H. Kaneto, T. Matsuoka, 2017, Diabetes.

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)

I. Shimomura, H. Kaneto, H. Yokoyama, 2016, Diabetes Care.

Changes in carotid intima‐media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima‐Media Thickness Evaluation

I. Shimomura, H. Watada, M. Gosho, 2017, Journal of diabetes investigation.

Carotid ultrasonography: A potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients

I. Shimomura, H. Kaneto, N. Katakami, 2013, Journal of diabetes investigation.

Saliva and Plasma Reflect Metabolism Altered by Diabetes and Periodontitis

E. Fukusaki, I. Shimomura, H. Nishizawa, 2021, Frontiers in Molecular Biosciences.

Clinical utility of carotid ultrasonography: Application for the management of patients with diabetes

I. Shimomura, T. Matsuoka, N. Katakami, 2019, Journal of diabetes investigation.

Transforming growth factor β1 T868C gene polymorphism is associated with cerebral infarction in Japanese patients with type 2 diabetes.

I. Shimomura, H. Kaneto, Y. Yamasaki, 2011, Diabetes research and clinical practice.

Short‐ and long‐term effect of sitagliptin after near normalization of glycemic control with insulin in poorly controlled Japanese type 2 diabetic patients

I. Shimomura, H. Kaneto, M. Matsuhisa, 2013, Journal of diabetes investigation.

Efficacy of liraglutide therapy in Japanese type 2 diabetic patients insufficiently controlled with basal‐supported oral therapy

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Journal of diabetes investigation.

Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2010, Mediators of inflammation.

Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes.

H. Kaneto, T. Matsuoka, T. Miyatsuka, 2007, Current molecular medicine.

Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients

Y. Nakamura, H. Kaneto, T. Miyatsuka, 2006, Diabetologia.

Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Diabetes research and clinical practice.

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

I. Shimomura, H. Kaneto, H. Yokoyama, 2015, Diabetes Care.

Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)

I. Shimomura, H. Kaneto, H. Yokoyama, 2014, Diabetology & Metabolic Syndrome.

Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).

I. Shimomura, H. Kaneto, H. Yokoyama, 2013, Journal of atherosclerosis and thrombosis.

Pathophysiology and early diagnosis of diabetic macroangiopathy

N. Katakami, 2013, Diabetology International.

Role of Pim-1 in Smooth Muscle Cell Proliferation*

H. Kaneto, M. Matsuhisa, M. Hori, 2004, Journal of Biological Chemistry.

Type 2 diabetes and atherosclerosis: focusing on metabolic syndrome

T. Funahashi, I. Shimomura, H. Kaneto, 2013, Diabetology International.

Different Impacts of Cardiovascular Risk Factors on Arterial Stiffness versus Arterial Wall Thickness in Japanese Patients with Type 2 Diabetes Mellitus.

I. Shimomura, T. Matsuoka, M. Takahara, 2015, Journal of atherosclerosis and thrombosis.

Shared and additional risk factors for decrease of toe-brachial index compared to ankle-brachial index in Japanese patients with diabetes mellitus.

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Atherosclerosis.

Assessment of vibratory sensation with a tuning fork at different sites in Japanese patients with diabetes mellitus

I. Shimomura, H. Kaneto, T. Matsuoka, 2013, Journal of Diabetes Investigation.

Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study

E. Fukusaki, T. Bamba, I. Shimomura, 2019, Journal of atherosclerosis and thrombosis.

Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Endocrine.

The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus: Principal Results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) Study: A Randomized Trial

Y. Yamasaki, R. Kawamori, N. Katakami, 2010, Circulation.

The utility of ultrasonic tissue characterization of carotid plaque in the prediction of cardiovascular events in diabetic patients.

Yasunori Ueda, Satoru Sumitsuji, I. Shimomura, 2013, Atherosclerosis.

The Utility of Carotid Ultrasonography in Identifying Severe Coronary Artery Disease in Asymptomatic Type 2 Diabetic Patients Without History of Coronary Artery Disease

I. Shimomura, H. Kaneto, Y. Irie, 2013, Diabetes Care.

Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2008, Diabetes & vascular disease research.

Accumulation of Gene Polymorphisms Related to Plaque Disruption and Thrombosis Is Associated With Cerebral Infarction in Subjects With Type 2 Diabetes

I. Shimomura, H. Kaneto, M. Matsuhisa, 2009, Diabetes Care.

Genetic risk factors and the anti-atherosclerotic effect of pioglitazone on carotid atherosclerosis of subjects with type 2 diabetes--a retrospective study.

H. Kaneto, M. Matsuhisa, R. Kawamori, 2010, Journal of atherosclerosis and thrombosis.

Ultrasonic Tissue Characterization of Carotid Plaque Improves the Prediction of Cardiovascular Events in Diabetic Patients

I. Shimomura, H. Kaneto, Y. Yamasaki, 2012, Diabetes Care.

Maximum carotid intima-media thickness improves the prediction ability of coronary artery stenosis in type 2 diabetic patients without history of coronary artery disease.

I. Shimomura, H. Kaneto, Y. Irie, 2012, Atherosclerosis.

alpha-Glucosidase inhibitor reduces the progression of carotid intima-media thickness.

M. Matsuhisa, M. Hori, Y. Yamasaki, 2005, Diabetes research and clinical practice.

Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan

I. Shimomura, T. Shiraiwa, M. Takahara, 2021, Journal of Diabetes Investigation.

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study

I. Shimomura, H. Kaneto, H. Yokoyama, 2017, Diabetes Therapy.

Long-term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity.

Y. Yamasaki, K. Kitagawa, H. Daida, 2010, Journal of atherosclerosis and thrombosis.

Association of Diabetes and Hemodialysis With Ankle Pressure and Ankle-Brachial Index in Japanese Patients With Critical Limb Ischemia

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Diabetes Care.

The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia

I. Shimomura, H. Kaneto, T. Matsuoka, 2010, Diabetes Care.

Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes.

T. Miyatsuka, M. Hori, Y. Yamasaki, 2003, Diabetes care.

Glucotoxicity-induced suppression of Cox6a2 expression provokes β-cell dysfunction via augmented ROS production.

J. Miyazaki, I. Shimomura, T. Matsuoka, 2021, Biochemical and biophysical research communications.

Role of MafA in pancreatic beta-cells.

H. Kaneto, T. Matsuoka, T. Miyatsuka, 2009, Advanced drug delivery reviews.

Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

I. Shimomura, H. Kaneto, H. Yokoyama, 2021, Cardiovascular Diabetology.

Predictive factors for the efficacy of switch to oral hypoglycemic agents in Japanese type 2 diabetic patients with intensive insulin therapy temporarily introduced.

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Endocrine journal.

Letter to the Editor from Watanabe: "Long-term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study".

I. Shimomura, M. Takahara, N. Katakami, 2021, Journal of Clinical Endocrinology and Metabolism.

Different impacts of metabolic profiles on future risk of cardiovascular disease between diabetes with and without established cardiovascular disease: the Japan diabetes complication and its prevention prospective study 7 (JDCP study 7)

Y. Yamasaki, N. Tajima, Y. Hayashino, 2021, Acta Diabetologica.

Recent Advances of Intervention to Inhibit Progression of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes Mellitus

Y. Yamasaki, H. Yokoyama, N. Katakami, 2006, Stroke.

Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol

I. Shimomura, H. Watada, M. Takahara, 2017, Diabetes Therapy.

Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients

I. Shimomura, T. Matsuoka, Y. Yamasaki, 2014, Cardiovascular Diabetology.

Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes

I. Shimomura, H. Watada, Y. Kojima, 2021, Cardiovascular Diabetology.

Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes

E. Fukusaki, T. Bamba, I. Shimomura, 2020, Cardiovascular Diabetology.

Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study

I. Shimomura, H. Watada, T. Yajima, 2020, Diabetes Therapy.

Clinical Utility of Carotid Ultrasonography in the Prediction of Cardiovascular Events in Patients with Diabetes: A Combined Analysis of Data Obtained in Five Longitudinal Studies

I. Shimomura, T. Matsuoka, Y. Irie, 2018, Journal of atherosclerosis and thrombosis.

Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling

H. Kaneto, T. Matsuoka, K. Kaku, 2020, International journal of molecular sciences.

Plasma pentraxin 3 levels are associated with carotid IMT in type 1 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2013, Diabetes Research and Clinical Practice.

Pancreatic beta cell function in lean and obese Japanese with various degrees of glucose tolerance.

I. Shimomura, H. Kaneto, M. Takahara, 2013, Endocrine journal.

Association of coronary artery stenosis with carotid atherosclerosis in asymptomatic type 2 diabetic patients.

H. Kaneto, Y. Irie, Y. Umayahara, 2011, Journal of atherosclerosis and thrombosis.

The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis

I. Shimomura, H. Watada, H. Ishii, 2017, Diabetes Therapy.

Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes.

M. Matsuhisa, M. Hori, Y. Yamasaki, 2002, Diabetes care.

Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis

I. Shimomura, H. Watada, M. Gosho, 2017, Diabetes Therapy.

Randomized Trial the Diabetic Atherosclerosis Prevention by Cilostazol ( DAPC ) Study : A Atherosclerosis in Subjects With Type 2 Diabetes Mellitus : Principal Results of The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid

Y. Yamasaki, R. Kawamori, N. Katakami, 2010 .

Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes

I. Shimomura, M. Takahara, N. Katakami, 2022, Journal of diabetes investigation.

Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus

I. Shimomura, H. Kaneto, H. Watada, 2017, Scientific Reports.

A candidate gene approach to genetic contributors to the development of IgA nephropathy.

Y. Yamasaki, H. Rakugi, Y. Isaka, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Risk categorization for calculating net reclassification improvement

I. Shimomura, H. Kaneto, M. Takahara, 2013, European Journal of Epidemiology.

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

I. Shimomura, H. Kaneto, T. Matsuoka, 2023, Cardiovascular Diabetology.

Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER

I. Shimomura, H. Watada, T. Yajima, 2021, Diabetes Therapy.

Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes

I. Shimomura, H. Watada, M. Gosho, 2019, Diabetes Therapy.

Association between new onset diabetic retinopathy and monocyte chemoattractant protein-1 (MCP-1) polymorphism in Japanese type 2 diabetes.

I. Shimomura, T. Matsuoka, Y. Yamasaki, 2015, Diabetes research and clinical practice.

Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2010, Diabetes research and clinical practice.

The impact of new-onset diabetes on arterial stiffness after renal transplantation.

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2008, Endocrine journal.

Aldose reductase C-106T gene polymorphism is associated with diabetic retinopathy in Japanese patients with type 2 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes research and clinical practice.

Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial

I. Shimomura, H. Nishizawa, T. Ohira, 2023, Frontiers in Endocrinology.

Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period

I. Shimomura, T. Matsuoka, T. Yasuda, 2019, Journal of Diabetes Investigation.

Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes

I. Shimomura, T. Yasuda, H. Watada, 2021, Cardiovascular Diabetology.

No association of diabetic duration or insulin use with the prognosis of critical limb ischemia after endovascular therapy.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Journal of atherosclerosis and thrombosis.

Plasma lipopolysaccharide binding protein level statistically mediates between body mass index and chronic microinflammation in Japanese patients with type 1 diabetes

I. Shimomura, T. Matsuoka, D. Kawamori, 2020, Diabetology International.

Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2010, Atherosclerosis.

Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L

I. Shimomura, T. Matsuoka, O. Tomonaga, 2018, Acta Diabetologica.

The risk factors associated with ultrasonic tissue characterization of carotid plaque in type 2 diabetic patients.

I. Shimomura, H. Kaneto, Y. Irie, 2014, Journal of diabetes and its complications.

Acute effects of whole body vibration exercise on post-load glucose metabolism in healthy men: a pilot randomized crossover trial

I. Shimomura, T. Kanamoto, M. Takahara, 2021, Endocrine.

Combined effect of oxidative stress-related gene polymorphisms on the progression of carotid atherosclerosis in Japanese type 2 diabetes.

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2009, Atherosclerosis.

Cumulative Effect of Oxidative Stress–Related Gene Polymorphisms on Myocardial Infarction in Type 2 Diabetes

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2009, Diabetes Care.

Improved lipid profiles are associated with reduced incidence of coronary vascular events in asymptomatic patients with type 2 diabetes and impaired myocardial perfusion.

H. Kaneto, Y. Yamasaki, K. Nakajima, 2013, Journal of atherosclerosis and thrombosis.

Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study

I. Shimomura, H. Kaneto, T. Yasuda, 2023, Scientific reports.

Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus

I. Shimomura, T. Shiraiwa, M. Takahara, 2022, BMC Endocrine Disorders.

Utility of Carotid Wall Shear Stress as a Predictor of Coronary Atherosclerosis.

N. Katakami, 2016, Journal of atherosclerosis and thrombosis.

Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.

M. Matsuhisa, A. Kuroda, M. Takahara, 2023, Journal of diabetes.

Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis.

H. Kaneto, M. Matsuhisa, M. Hori, 2009, Biochemical and biophysical research communications.

Y. Yamasaki, R. Kawamori, N. Katakami, 2010, Circulation.

Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin—a post-hoc analysis of the UTOPIA study

H. Watada, N. Katakami, T. Mita, 2024, Diabetology International.

Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes

I. Shimomura, H. Watada, M. Gosho, 2023, Diabetologia.

Psychosocial conditions and the progression of diabetic nephropathy in Japanese with type 2 diabetes mellitus

I. Shimomura, T. Matsuoka, M. Takahara, 2021, Diabetology International.

Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus

M. Takahara, N. Katakami, M. Waguri, 2024, Journal of diabetes investigation.

Clinical utility of carotid ultrasonography: Application for the management of patients with diabetes

I. Shimomura, T. Matsuoka, N. Katakami, 2019, Journal of diabetes investigation.

Preoperative fundus examination in patients with diabetes scheduled for surgery

I. Shimomura, T. Matsuoka, M. Takahara, 2020, Journal of diabetes investigation.

Endogenous secretory receptor for advanced glycation end product levels are inversely associated with HbA1c in type 2 diabetic patients.

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2006, Diabetes care.